CClinicalTrials.gg
RecruitingNCT06082024Updated Oct 13, 2023

Correlation Between Perioperative EEG Features and Delirium After General Anesthesia

An observational study in Perioperative Period, Anesthetic and Postoperative Cognitive Dysfunction, sponsored by Fuzhou Hua. Recruiting at 1 site in China. Open to participants aged 65 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-10-13.

Sponsored by Fuzhou Hua · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2023; still recruiting 3 years 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
40
Ages
65 Years to 80 Years
Sex
All
01

Study summary

The goal of this observational study is to compare the perioperative EEG characteristics and the incidence of short-term cognitive dysfunction in patients with postoperative delirium and non-postoperative delirium after elderly (> 65 years old) patients undergoing major gastrointestinal surgery under general anesthesia. The main question it aims to answer are: • The correlation between postoperative cognitive dysfunction and postoperative EEG features was evaluated.• To analyze the correlation between EEG characteristics and clinical risk factors of delirium after major abdominal gastrointestinal surgery under general anesthesia in elderly patients.Participants will collect EEG before and after operation and collect the incidence of postoperative cognitive function to explore the mechanism of postoperative delirium and predict postoperative cognitive dysfunction.

02

Conditions studied

  • Perioperative Period
  • Anesthetic
  • Postoperative Cognitive Dysfunction
  • Postoperative Delirium

Keywords

  • Perioperative period
  • Anesthetics
  • Postoperative Cognitive Dysfunction
  • postoperative delirium
03

In context

Delirium

1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.

This study's planned enrollment of 40 is below the median of 200 across 418 observational studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Fuzhou Hua is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who met the inclusion and exclusion criteria for gastrointestinal surgery admitted to the Second Affiliated Hospital of Nanchang University.

Inclusion criteria

  1. Education level in primary school or above;
  2. Age ≥65 years old, gender is not limited;
  3. Good communication ability, language expression ability, mental state and consciousness state;
  4. Preoperative simple mental state scale score ≥27 points;
  5. no history of craniocerebral diseases;
  6. For patients who plan to choose abdominal surgery under general anesthesia, the operation time is expected to be about 2h-4h;
  7. ASA anesthesia grade I \~ III;
  8. No general anesthesia contraindications;
  9. Sign informed consent voluntarily;

Exclusion criteria

Exclusion Criteria:

  1. Relative contraindications of general anesthesia: patients with serious heart and lung function diseases, drug allergy history, etc.
  2. Patients with a history of mental illness or long-term psychiatric drugs (dementia, schizophrenia), chronic analgesic drug use history, alcoholism history and cognitive dysfunction;
  3. any cerebrovascular accident occurred within 3 months, such as stroke, transient ischemic attack (TIA), etc.
  4. Diabetic patients with severe diabetic complications (diabetic ketoacidosis, hyperosmolar coma, various infections, macrovascular disease, diabetic nephropathy);
  5. Chronic hypoxia and carbon dioxide storage, such as chronic obstructive emphysema;
  6. a long history of alcohol abuse;
  7. Unable to cooperate to complete the test, the patient or family rejected the participant.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • delirium

    Patients present with delirium within 7 days after general anesthesia

  • non delirium

    The patient did not develop delirium for 7 days after general anesthesia

06

What researchers measure

Primary outcomes

  1. wave time-frequency analysis

    The characteristics of four kinds of brain wave α, β ,δ and θ were analyzed by professional EEG analysis software

    Time frame: one day before surgery, 7-10 days after surgery

  2. P300 latency and peak changes

    The feature analysis of event-related potentials was carried out through professional EEG analysis software

    Time frame: one day before surgery, 7-10 days after surgery

  3. EEG event-related potential accuracy and response time

    The accuracy of task EEG was analyzed statistically by using professional EEG analysis software

    Time frame: one day before surgery, 7-10 days after surgery

  4. Incidence of postoperative short-term cognitive dysfunction

    A telephone return visit was conducted on patients using the Revised Cognitive Function Telephone Questionnaire (TICS-M) at 1, 3, and 6 months after discharge.The total score was less than 28 points, which was considered as cognitive impairment.

    Time frame: postoperative 1,3,6 months

Secondary outcomes

  1. Systolic pressure

    "just entering the operating room", "immediately after intubation", "every 5 minutes after intubation until the patient leaves the operating room".

    Time frame: perioperative period

  2. Diastolic pressure

    "just entering the operating room", "immediately after intubation", "every 5 minutes after intubation until the patient leaves the operating room".

    Time frame: perioperative period

  3. Mean pressure

    "just entering the operating room", "immediately after intubation", "every 5 minutes after intubation until the patient leaves the operating room".

    Time frame: perioperative period

  4. Heart rate

    "just entering the operating room", "immediately after intubation", "every 5 minutes after intubation until the patient leaves the operating room".

    Time frame: perioperative period

  5. Maximum postoperative C-reactive protein (CRP)

    Only the highest CRP values detected in the normal course of gastrointestinal surgery are collected, and no additional blood sampling or interventions are performed

    Time frame: Up to 1 month after surgery

  6. Minimum postoperative albumin

    Only the lowest albumin values detected in the normal course of gastrointestinal surgery are collected, and no additional blood sampling or interventions are performed

    Time frame: Up to 1 month after surgery

  7. Postoperative pain

    The degree of postoperative pain was assessed using the Numerical Rating Scale (NRS). The pain level increased sequentially from 0-10

    Time frame: 1, 3, and 7 days after surgery

  8. Complication

    All the perioperative complications are recorded

    Time frame: During the perioperative period, up to 1 month after surgery

  9. Length of hospitalization

    The total number of days the patient spent at the hospital for the current consultation

    Time frame: After the patient is discharged from the hospital, average 1 month

07

Study locations

1 of 1 sites recruiting
  • the Second Affiliated Hospital of Nanchang University, Nanchang University
    Jiangxi, NanChang, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06082024
Lead sponsor
Fuzhou Hua
Responsible party
Fuzhou Hua (Director, Second Affiliated Hospital of Nanchang University) — Sponsor-investigator
First posted
Oct 13, 2023
Start date
Apr 13, 2023
Primary completion
Jun 2024 (estimated)
Completion
Jun 2024 (estimated)
Last update
Oct 13, 2023

Study contacts

Fuzhou Hua
Contact
huafuzhou@126.com
15170238929
Xiuqin Rao
Contact
raoxiuqin98@163.com
18270739733
Fuzhou Hua
study director · Second Affiliated Hospital of Nanchang University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion